​

BioStem Technologies Ownership | Who Owns BioStem Technologies?


OverviewRevenueFinancialsChartTranscripts

BioStem Technologies Ownership Summary


BioStem Technologies is owned by 30.55% insiders, and 69.45% retail investors.

BSEM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioStem Technologies-30.55%69.45%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20261-74---1---

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q3--

BSEM Ownership FAQ


Who Owns BioStem Technologies?

BioStem Technologies shareholders are primarily institutional investors at 0.00%, followed by 30.55% insiders and 69.45% retail investors. The average institutional ownership in BioStem Technologies's industry, Biotech Stocks , is 181.71%, which BioStem Technologies falls below.

Does Blackrock own BioStem Technologies?

BlackRock is not among the top 10 institutional shareholders of BioStem Technologies.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools